Gene Signal develops angiogenesis-based medicines focused on ophthalmology treatments, particularly targeting corneal neovascularization.

Gene Signal

Gene Signal | 39 followers on LinkedIn. Gene Signal is a research and development based biotechnology company focused on discovering genes involved in the regulation of angiogenesis. Gene Signal&#39;s ophthalmic research program is pioneering targeted upstream blockade of pathological angiogenesis through the inhibition of Insulin Receptor Susbtrate 1 (IRS-1).

Chef d'entreprise, Gene Signal

Al-Mahmood Salman

Google Analytics

Google Analytics Classic

Shockwave Flash Embed

TYPO3

Fonts.com

Eric Viaud

Co-Founder

Switzerland Companies With Less Than $10M in Revenue (Top 10K)

Switzerland Companies With Fewer Than 100 Employees (Top 10K)

Health Care Seed Stage Companies With More Than 10 Employees

Switzerland Seed Stage Companies With More Than $1M in Revenue

Gene Signal is a research and development based biotechnology company focused on discovering genes involved in the regulation of angiogenesis.

Gene Signal's ophthalmic research program is pioneering targeted upstream blockade of pathological angiogenesis through the inhibition of Insulin Receptor Substrate 1 (IRS-1)

Seed Round - Gene Signal

Lausanne

Vaud

Switzerland

Europe

China

Asia

jQuery

Adobe Flash

Apache Server

Genesignal provides diagnostic services focusing on the detection of various medical conditions through advanced testing methodologies. self-described.

Genesignal

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 13, 2024 2:37 PM	83428d8f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 13, 2024 2:37 PM	2ca7ed61
crunchbase trigger	general	Nov 13, 2024 2:37 PM	b0205bd1
crunchbase profile	general	Nov 14, 2024 1:50 AM	8b657f63
li profile	general	Nov 13, 2024 2:37 PM	cf8d072c
translate crunchbase fundingrounds	general	Nov 14, 2024 2:28 AM	c831e115
peers	general	Nov 13, 2024 2:37 PM	6ee1a186
news basic	general	Nov 13, 2024 2:37 PM	7e42734d
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

GENE

COM:GENESIGNAL

Gene Signal